# 【AstraZeneca】【R&D】Hematology & Early Dev Oncology TA VP at AstraZeneca

AstraZeneca is hiring a 【AstraZeneca】【R&D】Hematology & Early Dev Oncology TA VP in Osaka, Japan. Level rates it Little AI ●○○○; you can [apply on AstraZeneca](https://jobsbylevel.com/go/c5bf3448-d6ab-4513-833c-6cfc160dbe17?utm_medium=ai-agent).

AI Level 1, AI centrality 0 out of 100. Japan - Osaka.

## Details

- Company: [AstraZeneca](https://jobsbylevel.com/companies/astrazeneca)
- AI level: AI Level 1 (score 0 out of 100)
- Location: Japan - Osaka
- Posted: July 27, 2026
- Apply: https://jobsbylevel.com/go/c5bf3448-d6ab-4513-833c-6cfc160dbe17?utm_medium=ai-agent
- Free CV review for this job: https://jobsbylevel.com/cv-review?job=astrazeneca-r-d-hematology-early-dev-oncology-ta-vp-at-astrazeneca-256e12

## Prepare for this job

The job page lists 5 likely interview questions for this offer, with a CV checklist: https://jobsbylevel.com/jobs/astrazeneca-r-d-hematology-early-dev-oncology-ta-vp-at-astrazeneca-256e12

## Description

【Job Description】 The Japan Therapy Area Head (J-TA head) in R&D Japan is overall accountable for delivery of all projects strategy led by Product Leaders (PLs) in the relevant TA. The J-TA Head leads the R&D Japan TA division, which consists the Product Leaders Project Physicians, and Clinical Scientist and oversees TA-specific teams under each TA Head. The J-TA Head is responsible for providing TA and Disease Area (DA) expertise & input to relevant TALT for the TA/DA strategy development. The J-TA Head is accountable for the Japan TA portfolio strategy and prioritizes the projects within the responsible TA from the view points of the resource, PTS, eNPV and the cannibalization of the values among the projects. The J-TA Head is responsible for the development of the PL(s) and TA-specific team leaders. The J-TA head ensure the group delivers the required business contribution within agreed manpower and revenue budgets. 【Accountabilities/Responsibilities - Drug Project Environment】 TA strategy(ies), DA strategy(ies) and product development strategy(ies) are in line with ■TALT business objectives, securing optimum market access of the TA pipeline ・Lead definition and revision of Japan TA division objectives for product development. ・Lead definition and revision of Japan TA division objectives for product development. ・With global colleagues co-create the TA and/or DA strategy, and refine as necessary ・Lead PL(s) and ensure to co-create the development strategy for relevant product(s) for key Investment Decisions (IDs) ie.CSID, P2ID, P3ID, COMMID for senior leadership/governance body ・Lead Japan input to relevant TALT, GMed, iMed, Medi teams & communicate broad business context to Japan based colleagues ・Lead PL(s) to ensure to deliver tactical, cross-functional Japan development options and business cases, differing in risk, time and/or cost that are aligned with product strategy and challenges to ensure that they are robust and competitive ・Lead PL(s) and ensure to co-create the development strategy for relevant product(s) for key Investment Decisions (IDs) ie.CSID, P2ID, P3ID, COMMID for senior leadership/governance body ・Lead Japan input to relevant TALT, GMed, iMed, Medi teams & communicate broad business context to Japan based colleagues ・Lead PL(s) to ensure to deliver tactical, cross-functional Japan development options and business cases, differing in risk, time and/or cost that are aligned with product strategy and challenges to ensure that they are robust and competitive ■Local Scientific Leadership ・Develop knowledge of and use local market understanding to identify gaps between market need(s) and AZ portfolio or AZ capabilities ・Develop a future view of how local market needs may change and use this when creating strategy(ies) with global colleagues ・Be accountable for the local TA, DA, and products Ad Bds that are lead by the MSD. ■Risk and opportunity management across the TA ・Ensure a cross-functional risk and opportunity management process within the TA portfolio led by Therapeutic Area Project Manager (TAPM) ・Ensure that mitigation and contingency actions are agreed, activated, communicated and delivered as required ・Collaborate with other J-TA Head(s) to develop a view of cross portfolio risks and opportunities ■TA division effectiveness; associated Project Team(s) effectiveness, interfaces and communication to support effective delivery ・Ensure effective TA division management that division norms and ways of working are defined and followed ・Ensure effective communication and documentation within TA division and within Project Team(s) led by Product Leader(s) ・Ensure the TA contribution to the ‘portfolio reporting’ cycle including quarterly risk reporting to R&D Japan LT, product briefs and monthly snapshots, pipeline updates etc ・Guide TA division in understanding and integration of new business policies, initiatives and capabilities into TA division ways of working and into relevant product development plan

The description is cut here. Read the full offer: https://jobsbylevel.com/jobs/astrazeneca-r-d-hematology-early-dev-oncology-ta-vp-at-astrazeneca-256e12

Source: https://jobsbylevel.com/jobs/astrazeneca-r-d-hematology-early-dev-oncology-ta-vp-at-astrazeneca-256e12

## Cite this page

Level. https://jobsbylevel.com/jobs/astrazeneca-r-d-hematology-early-dev-oncology-ta-vp-at-astrazeneca-256e12.

Get job alerts: https://jobsbylevel.com/newsletter